Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: Influence of cell differentiation

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 705-715

  Cavicchi, M ^a   Whittle, B J R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

1400 W; Caco 2; Colonic epithelial cell line; Differentiation; Glucocorticoids; Inducible nitric oxide synthase; iNOS; JAK 2; NF B

Indexed keywords

3,4 DICHLOROISOCOUMARIN; ACETAMIDINE DERIVATIVE; CYTOKINE; DACTINOMYCIN; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; COLON MUCOSA; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CACO-2 CELLS; CELL DIFFERENTIATION; CYTOKINES; DEXAMETHASONE; DNA PRIMERS; HUMANS; INTESTINAL MUCOSA; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION, GENETIC; TYRPHOSTINS;

EID: 0032701107     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702827     Document Type: Article

References (50)

1. AMBS, S., MERRIAM, W.G., BENNETT, W.P., FELLEY-BOSCO, E., OGUNFUSIKA, M.O., OSER, S.M., KLEIN, S., SHIELDS, P.G., BILLIAR, T.R. & HARRIS, C.C. (1998). Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumour angiogenesis and colon cancer progression. Cancer Res., 58, 334-341.
2. BAEUERLE, P.A. (1998). Pro-inflammatory signaling: Last pieces in the NF-kappaB puzzle? Curr. Biol., 8, R19-R22.
3. BOUGHTON-SMITH, N.K., EVANS, S.M., HAWKEY, C.J., COLE, A.T., BALSITIS, M., WHITTLE, B.J.R. & MONCADA, S. (1993). Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet, 342, 338-340.
4. BRISKE-ANDERSON, M.J., FINLEY, J.W. & NEWMAN, S.M. (1997). The influence of cultured time and passage number on the morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med., 214, 248-257.
5. BRYANT, C.E., PERRETTI, M. & FLOWER, R.J. (1998). Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: A possible role for lipocortin I. Biochem. Pharmacol., 55, 279-285.
6. DEXTER, D.L., SPREMULLI, E.N., FLIGIEL, Z., BARBOSA, J.A., VOGEL, R., VAN VOORHEEES, A. & CALABRESI, P. (1981). Heterogeneity of cancer cells from a single human colon carcinoma. Am. J. Med., 71, 949-956.
7. DIAS, V.C., SHAFFER, E.A., WALLACE, J.L. & PARSONS, H.G. (1994). Bile salts determine leukotriene B4 synthesis in a human intestinal cell line (CaCo-2). Dig. Dis. Sci., 39, 802-808.
8. FÖRSTERMANN, U., GATH, I., SCHWARZ, P., CLOSS, E.I. & KLEINERT, H. (1995). Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol., 50, 1321-1332.
9. GELLER, D.A., NUSSLER, A.K., DI SILVIO, M., LOWENSTEIN, C.J., SHAPIRO, R.A., WANG, S.C., SIMMONS, R.I., & BILLIAR, T.R. (1993). Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci., 90, 522-526.
10. HANAUER, S.B. (1996). Inflammatory bowel disease. N. Engl. J. Med., 334, 841-848.
11. HECKER, M., PREISS, C., KLEMM, P. & BUSSE, R. (1996). Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: Role of nuclear factor κB and interferon regulatory factor I. Br. J. Pharmacol., 118, 2178-2184.
12. JENKINS, D.C., CHARLES, I.G., BAYLIS, S.A., LELCHUK, R., RADOMSKI, M.W. & MONCADA, S. (1994). Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer, 70, 847-849.
13. JENKINS, D.C., CHARLES, I.G., THOMSEN, L.L., MOSS, D.W., HOLMES, L.S., BAYLIS, S.A., RHODES, P., WESTMORE, K., EMSON, P.C. & MONCADA, S. (1995). Roles of nitric oxide in tumour growth. Proc. Natl. Acad. Sci., 92, 4392-4396.
14. JOBIN, C., HASKILL, S., MAYER, L., PANJA, A. & SARTOR, R.B. (1997). Evidence for altered regulation of IκBα degradation in human colonic cells. J. Immunol., 158, 226-234.
15. KLEINERT, H., EUCHENHOFER, C., FRITZ, G., IHRIG-BIEDERT, I. & FÖRSTERMANN, U. (1998a). Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br. J. Pharmacol., 123, 1716-1722.
16. KLEINERT, H., EUCHENHOFER, C., IHRIG-BIEDERT, I. & FÖRSTERMANN, U. (1996a). In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB. J. Biol. Chem., 271, 6039-6044.
17. KLEINERT, H., EUCHENHOFER, C., IHRIG-BIEDERT, I. & FÖRSTERMANN, U. (1996b). Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol., 49, 15-21.
18. KLEINERT, H., WALLERATH, T., FRITZ, G., IHRIG-BIEDERT, I., RODRIGUEZ-PASCUAL, F., GELLER, D.A. & FÖRSTERMANN, U. (1998b). Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br. J. Pharmacol., 125, 193-201.
19. KNOWLES, R.G. & MONCADA, S. (1994). Nitric oxide synthases in mammals. Biochem. J., 298, 249-258.
20. KOLIOS, G., BROWN, Z., ROBSON, R.L., ROBERTSON, D.A.F. & WESTWICK, J. (1995). Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br. J. Pharmacol., 116, 2866-2872.
21. KUNZ, D., WALKER, G., EBERHARDT, W. & PFEILSCHIFTER, J. (1996). Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci., 93, 255-259.
22. LINN, S.C., MORELLI, P.J., EDRY, I., COTTONGIM, S.E.M., SZABÓ, C. & SALZMAN, A.L. (1997). Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am. J. Physiol., 35, G1499-G1508.
23. MCLAUGHLAN, J.M., SETH, R., VAUTIER, G., ROBINS, R.A., SCOTT, B.B., HAWKEY, C.J. & JENKINS, D. (1997). Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J. Pathol., 181, 87-92.
24. MEYDAN, N., GRUNBERGER, T., DADI, H., SHAHAR, M., ARPAIA, E., LAPIDOT, Z., LEEDER, J.S., FREEDMAN, M., COHEN, A., GAZIT, A., LEVITZKI, A. & ROIFMAN, C.M. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-648.
25. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
26. MORIN, M.J., UNNO, N., HODIN, R.A. & FINK, M.P. (1998). Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit. Care Med., 26, 1258 1264.
27. MULLER, J.M., RUPEC, R.A. & BAEUERLE, P.A. (1997). Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods, 11, 301-312.
28. NUNOKAWA, Y., OIKAWA, S. & TANAKA, S. (1996). Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem. Biophys. Res. Commun., 223, 347-352.
29. NUSSLER, A.K., LIU, Z.Z., HATAKEYAMA, K., GELLER, D.A., BILLIAR, T.R. & MORRIS, JR S.M. (1996). A cohort of supporting metabolic enzymes is coinduced with nitric oxide synthase in human tumour cell lines. Cancer Lett., 103, 79-84.
30. O'FLAHERTY, L., STAPLETON, P.P., REDMOND, H.P. & BOUCHIER-HAYES, D. (1997). Dexamethasone and lipopolysaccharide regulation of taurine transport in Caco-2 cells. J. Surg. Res., 69, 331-336.
31. PFAHL, M. (1993). Nuclear receptor/AP-1 interaction. Endoc. Rev., 14, 651-658.
32. QUARONI, A., WANDS, J., TRELSTAD, T.L. & ISSELBACHER, K.J. (1979). Epithelial cell cultures from rat small intestine. J. Cell. Biol., 80, 245-265.
33. RACHMILEWITZ, D., STAMLER, J.S., BACHWICH, D., KARMELI, F., ACKERMAN, Z. & PODOLSKY, D.K. (1995). Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut, 36, 718-723.
34. RADOMSKI, M.W., JENKINS, D.C., HOLMES, L. & MONCADA, S. (1991). Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51, 6073-6078.
35. REINECKER, H.C., LOH, E.Y., RINGLER, D.J., MEHTA, A., ROMBEAU, J.L. & MACDERMOTT, R.P. (1995). Monocyte-chemoattractant protein I gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology, 108, 40-50.
36. SALZMAN, A.L., DENENBERG, A.G., UETA, I., O'CONNOR, M., LINN, S.C. & SZABÓ, C. (1996). Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am. J. Physiol., 270, G565-G573.
37. SALZMAN, A.L., EAVES-PYLES, T., LINN, S.C., DENENBERG, A.G. & SZABÓ, C. (1998). Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology, 114, 93-102.
38. SAURA, M., ZARAGOZA, C., DIAZ-CAZORLA, M., HERNANDEZ-PERERA, O., ENG, E., LOWENSTEIN, C.J., PEREZ-SALA, D. & LAMAS, S. (1998). Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int., 53, 38-49.
39. SCHRECK, R., MEIER, B., MÄNNEL, D.N., DRÖGE, W. & BAEUERLE, P.A. (1992). Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med., 175, 1181 1194.
40. SHERMAN, P.A., LAUBACH, V.E., REEP, B.R. & WOOD, E.R. (1993). Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumour cell line. Biochemistry, 32, 11600-11605.
41. SIMMONS, W.W., UNGUREANU-LONGROIS, D., SMITH, G.K., SMITH, T.W. & KELLY, R.A. (1996). Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J. Biol. Chem., 271, 23928-23937.
42. SINGER, I.I., KAWKA, D.W., SCOTT, S., WEIDNER, J.R., MUMFORD, R.A., RIEHL, T.E. & STENSON, W.F. (1996). Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology, 111, 871-885.
43. TEPPERMAN, B.L., BROWN, J.F., KOROLKIEWICZ, R. & WHITTLE, B.J.R. (1994). Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: Effect of endotoxin challenge. J. Pharmacol. Exp. Ther., 271, 1477-1482.
44. TEPPERMAN, B.L., BROWN, J.F. & WHITTLE, B.J.R. (1993). Nitric oxide synthase induction and intestinal cell viability in rats. Am. J. Physiol., 265, G214-G218,
45. UNNO, N., MENCONI, M.J., SMITH, M. & FINK, M.P. (1995). Nitric oxide mediated interferon-γ-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit. Care Med., 23, 1170-1176.
46. VECCHINI, F., PRINGAULT, E., BILLIAR, T.R., GELLER, D.A., HAUSEL, P. & FELLEY-BOSCO, E. (1997). Decreased activity of inducible nitric oxide synthase type 2 and modulation of the expression of glutathione S-transferase, bcl-2, and methallothioneins during the differentiation of CaCo-2 cells. Cell Growth Differ., 8, 261-268.
47. WEBER-NORDT, R.M., MERTELSMANN, R. & FINKE, J. (1998). The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation. Leuk. Lymphoma, 28, 459-467.
48. WHITTLE, B.J.R. (1997). Nitric oxide a mediator of inflammation or mucosal defence. Eur. J. Gastroenterol. Hepatol., 9, 1026-1032.
49. WU, K.K. (1995). Inducible cyclooxygenase and nitric oxide synthase. Adv. Pharmacol., 33, 179-207.
50. ZWEIBAUM, A., LABURTHE, M., GRASSET, E. & LOUVARD, D. (1991). Use of cultured cell lines in studies of intestinal cell differentiation and function. In Field, M. & Frizzell, R.A. (ed) The gastrointestinal system. IV. Am. Physiol Soc.: Bethesda, MD. pp. 223-255.